Clinical research
Being tested in people in registered clinical trials. Being in trials is not evidence that a treatment works or is safe.
この試験で検証していること
The companion study to the sickle cell trial, in people with beta thalassemia who needed regular blood transfusions to live. The question was whether editing their own stem cells would let them stop. Most participants became transfusion-independent.
An open-label, single-arm Phase 2/3 study of exagamglogene autotemcel in patients aged 12–35 with transfusion-dependent beta thalassemia. The primary endpoint was transfusion independence, defined as maintaining a weighted average haemoglobin of at least 9 g/dL without transfusion for at least 12 consecutive months.
Sources
- New England Journal of Medicine · 2024
Exagamglogene autotemcel for transfusion-dependent β-thalassemia ↗
試験結果が意味すること・意味しないこと
初期段階の結果は少人数の参加者と短い追跡期間から得られたものです。参加者が増え時間が経つにつれて変わる可能性があり、募集中・実施中・完了済みの試験であっても、治療効果が確立されたわけではありません。登録基準は厳格で、適格性の判断は試験実施施設が行うものであり、ウェブサイトが行うものではありません。